Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention

Yuichiro Kitai(Kyoto University), Takeshi Kimura(Municipal Hirakata City Hospital), Bingyuan Bao(Kyoto University), Motoko Yanagita(Kyoto University), Yutaka Furukawa(Kobe City Medical Center General Hospital), Satoshi Shizuta(Kyoto University), Kazushige Kadota(Kurashiki Central Hospital), Yoshihisa Nakagawa(Shiga University of Medical Science), Takeshi Morimoto(Hyogo Medical University), Neiko Ozasa(Kyoto University)
International Journal of Cardiology
August 16, 2013
10.1016/j.ijcard.2013.08.029
Cited by 38

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
|New England Journal of Medicine|1996|507
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome
|Journal of the American College of Cardiology|2009|359